Dr. Priya U. Kumthekar
Claim this profileNorthwestern University
Studies Glioblastoma
Studies Brain Cancer
13 reported clinical trials
46 drugs studied
Area of expertise
1Glioblastoma
IDH negative
MET negative
TMB
2Brain Cancer
IDH negative
Stage IV
MET negative
Affiliated Hospitals
Clinical Trials Priya U. Kumthekar is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting1 award Phase 210 criteria
Targeted Therapy
for Brain Cancer
This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K, or KRAS G12C. Medications that target these genes such as abemaciclib, paxalisib, entrectinib and adagrasib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Genetic testing may help doctors tailor treatment for each mutation.
Recruiting1 award Phase 217 criteria
More about Priya U. Kumthekar
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Priya U. Kumthekar has experience with
- Radiation Therapy
- Bevacizumab
- Nivolumab
- Capivasertib
- Vismodegib
- Abemaciclib
Breakdown of trials Priya U. Kumthekar has run
Glioblastoma
Brain Cancer
Brain Tumor
Meningioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Priya U. Kumthekar specialize in?
Priya U. Kumthekar focuses on Glioblastoma and Brain Cancer. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET negative.
Is Priya U. Kumthekar currently recruiting for clinical trials?
Yes, Priya U. Kumthekar is currently recruiting for 7 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Priya U. Kumthekar has studied deeply?
Yes, Priya U. Kumthekar has studied treatments such as Radiation Therapy, Bevacizumab, Nivolumab.
What is the best way to schedule an appointment with Priya U. Kumthekar?
Apply for one of the trials that Priya U. Kumthekar is conducting.
What is the office address of Priya U. Kumthekar?
The office of Priya U. Kumthekar is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.